Lv2
180 积分 2025-12-06 加入
Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trial
29天前
已完结
Blood Pressure Management After Endovascular Therapy for Acute Ischemic Stroke
29天前
已完结
Intensive vs Conventional Blood Pressure Lowering After Endovascular Thrombectomy in Acute Ischemic Stroke
29天前
已完结
Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial
29天前
已完结
Efgartigimod for the treatment of Guillain–Barré syndrome with concurrent posterior reversible encephalopathy syndrome
2个月前
已完结
Efficacy and safety of efgartigimod in patients with neurological autoimmune diseases
2个月前
已完结
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
2个月前
已完结
皖公网安备34019202002308
